Literature DB >> 2643544

A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.

S Oguma1, S Belle, T E Starzl, A J Demetris.   

Abstract

Conspicuous pathologic features of chronic liver allograft rejection include bile duct loss and chronic obliterative arteriopathy. A quantitative histometric analysis was performed to document the extent of bile duct loss, the size of the "vanished" ducts and the extent of chronic obliterative arteriopathy and to determine whether there was any relationship between chronic obliterative arteriopathy and bile duct loss. All failed liver allograft specimens with chronic rejection were reviewed and categorized according to the degree of chronic obliterative arteriopathy, assessed by the degree of luminal narrowing of hilar hepatic artery branches. Histometric analysis of the grafts revealed: (i) there was a loss of small portal arterioles (less than 35 microns); (ii) bile ducts which should accompany arteries less than 35, 35 to 54 or 55 to 74 microns in diameter were missing, with the greatest decrease occurring among the smallest ducts; (iii) bile duct loss was seen in the absence of significant large vessel chronic obliterative arteriopathy, and (iv) the severity of arteriole and bile duct loss, as well as the size of the vanished ducts, was directly proportional to the degree of chronic obliterative arteriopathy. Furthermore, the size of the "vanished" bile ducts in liver allografts appeared to differ from the size of ducts destroyed in primary biliary cirrhosis. These studies offer indirect, but suggestive proof that two mechanisms are operative in the bile duct loss seen in chronic rejection: direct lymphocytotoxicity and ischemic damage.

Entities:  

Mesh:

Year:  1989        PMID: 2643544      PMCID: PMC2956434          DOI: 10.1002/hep.1840090207

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Functional characterization of infiltrating T lymphocytes in human hepatic allografts.

Authors:  J J Fung; A Zeevi; T E Starzl; J Demetris; S Iwatsuki; R J Duquesnoy
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

2.  Liver transplant rejection: angiographic findings in 35 patients.

Authors:  R M White; A B Zajko; A J Demetris; K M Bron; A Dekker; T E Starzl
Journal:  AJR Am J Roentgenol       Date:  1987-06       Impact factor: 3.959

3.  Biopsy findings in cases of rejection of liver allograft.

Authors:  S G Hubscher; D Clements; E Elias; P McMaster
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

Review 4.  A review of adult and pediatric post-transplant liver pathology.

Authors:  A J Demetris; R Jaffe; T E Starzl
Journal:  Pathol Annu       Date:  1987

5.  Cardiac transplant atherosclerosis.

Authors:  M E Billingham
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

6.  Vascular rejection and arteriosclerosis.

Authors:  S Oguma; H Okazaki; M Jimbo; A Iguchi; H Takahashi; M Ishizaki
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

7.  Electron microscopy of rejected human liver allografts.

Authors:  R H Fennell; J M Vierling
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

Review 8.  The syndrome of disappearing intrahepatic bile ducts.

Authors:  S Sherlock
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

9.  Pathologic analysis of liver transplantation for primary biliary cirrhosis.

Authors:  A J Demetris; B H Markus; C Esquivel; D H Van Thiel; S Saidman; R Gordon; L Makowka; G D Sysyn; T E Starzl
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

10.  Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.

Authors:  A J Demetris; S Lasky; D H Van Thiel; T E Starzl; A Dekker
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more
  28 in total

1.  Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.

Authors:  S Takaya; A Jain; A Yagihashi; K Nakamura; M Kobayashi; K Takeuchi; S Suzuki; Y Iwaki; A J Demetris; S Todo; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1999-08       Impact factor: 1.066

Review 2.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

4.  Peribiliary vascular diseases in rejected livers; computer-aided three-dimensional reconstruction and morphometry.

Authors:  M Takemura; S Oguma; S Mori; M Ishii; T E Starzl; A J Demetris; T Takahasi
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 5.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

6.  Interventional radiology: management of biliary complications of liver transplantation.

Authors:  Nishita Kothary; Aalpen A Patel; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2004-12       Impact factor: 1.513

7.  Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.

Authors:  A J Demetris; N Murase; T E Starzl; J J Fung
Journal:  Graft (Georget Tex)       Date:  1998-05

8.  Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.

Authors:  J C Arnold; K T Nouri-Aria; J G O'Grady; B C Portmann; G J Alexander; R Williams
Journal:  Clin Investig       Date:  1993-03

Review 9.  The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?

Authors:  A J Demetris; N Murase; C P Delaney; M Woan; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

10.  Liver transplantation in 100 children: Cambridge and King's College Hospital series.

Authors:  A Salt; G Noble-Jamieson; N D Barnes; A P Mowat; K Rolles; N Jamieson; P Johnston; P Friend; R Y Calne
Journal:  BMJ       Date:  1992-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.